GlassScriptPhysician profile
Peter Clegg Jeppson
NPI 1487879987
$11,422.47
in general payments reported to CMS, 2019-2025
26 companies · $968 in 2025
The $968 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.69 · 2021: $145 · 2022: $8,706 · 2023: $597 · 2024: $907 · 2025: $968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,471.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,536.83 | 2022-2023 | Da Vinci Surgical System |
| Valencia Technologies Corporation | $670.78 | 2022-2025 | Ecoin Device Kit |
| Boston Scientific Corporation | $644.04 | 2022-2024 | Solyx Sis System, Advantage System, Upsylon |
| Coloplast Corp | $600.65 | 2021-2025 | Speedicath, Saffron |
| Medtronic, INC. | $455.58 | 2023-2025 | Altaviva, Interstim, Truclear |
| Caldera Medical, INC | $401.79 | 2022-2025 | Desara |
| Abbvie INC. | $205.44 | 2022-2025 | |
| Femselect INC. | $204.24 | 2023-2025 | Enplace |
| Rochester Medical Corporation | $90.51 | 2022 | |
| Bluewind Medical | $87.44 | 2024 | |
| Sumitomo Pharma America, INC. | $66.08 | 2023-2025 | Gemtesa |
| 180 Medical, INC. | $55.19 | 2022-2023 | Gentlecath Glide |
| Millicent US INC | $52.76 | 2023-2024 | Intrarosa, Femring |
| Cook Medical LLC | $51.00 | 2019 | |
| Merck Sharp & Dohme LLC | $48.69 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $37.39 | 2023-2024 | Stratafix, Harmonic, Ethicon |
| Astellas Pharma US INC | $28.97 | 2025 | Veozah |
| Pharmacosmos Therapeutics INC. | $28.46 | 2022 | |
| Axonics, INC. | $25.23 | 2024 | Axonics |
| Smith+Nephew, INC. | $24.37 | 2023 | Stravix |
| Urovant Sciences INC | $21.79 | 2022 | |
| Laborie Medical Technologies Corp. | $20.77 | 2025 | |
| Teleflex LLC | $17.30 | 2024 | Solesta |
| Becton, Dickinson and Company | $16.63 | 2025 | |
| Coopersurgical, INC. | $16.10 | 2024 | Supercut Hysterectomy Scissors |
| Pfizer INC. | $14.44 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Jeppson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.